Taken together, these results indicate that β-elemene, via the major platinum influx transporter, potently enhanced oxaliplatin’s anti-HCC effect in vitro and in vivo by preventing oxaliplatin-induced degradation of hCTR1. The gene discussed is SLC31A1; the disease is hepatocellular carcinoma.